ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2022 Congress

Fibrinolysis and Proteolysis

Theme Navigation

  • ISTH 2022 Congress
    • Fibrinolysis and Proteolysis
      • Fibrinogen and Factor XIII
      • Fibrinolytic Factors and Inhibitors
      • Plasminogen Activation in the CNS and Immunity
      • Thrombolytic Therapy

Abstract Number: VPB0636

A Comparative Study Of Intravenous Bolus Versus Bolus With Continuous Infusion Of Tranexamic Acid To Reduce Blood Loss In Major Surgical Procedures

N. NEERU1, V. ABRAHAM2

Abstract Number: OC 76.2

A zebrafish model of dysfibrinogenemia caused by hotspot mutations in the human fibrinogen gamma chain

R. Fish1, M. Richard2, M. Neerman-Arbez3

Abstract Number: PB0632

Activity of some protease inhibitors in patients with arterial hypertension of high risk.

E. Shorikov1, D. Shorikova1, P. Shorikov2, A. Esmaeil2

Abstract Number: VPB0633

Adipokines and insulin resistance in young individuals with various metabolic phenotypes

V. Chulkov1, N. Vereina2, E. Gavrilova2, E. Lenets2, E. Pankova2, S. Martynov2, S. Sinitsin2

Abstract Number: PB0641

Alternative cleavage method of LPXTG motif in group A streptococcus by LPXTGase-like protein has a higher selectivity towards aromatic fourth position residues at the sortase A consensus sequence

B. Readnour1, Y. Ayinuola2, Z. Liang3, B. Russo3, V. Fischetti4, V. Ploplis5, F. Castellino5

Abstract Number: VPB0635

Attenuation of Thrombotic Biomarkers in a Hyperlipidaemic Sprague Dawley Rats Model

I. KWAIFA1, K. Perumal2, H. Bahari3, K. Yong3, Z. Eshak4, S. Balan5, A. Abidin5, F. Ghadi3, L. Kong3, S. NOOR3

Abstract Number: OC 29.1

Both α- and γ-chain crosslinks mediated by FXIIIa affect fibrin fibre resistance to rupture

T. Feller1, C. Duval2, S. Connell3, R. Ariëns4

Abstract Number: OC 46.5

Carbamylation in acute ischemic stroke thrombi impairs t-PA-mediated thrombolysis and increases thrombus frailty

V. Ollivier1, A. Freiherr Von Seckendorff2, M. Solo Nomenjanahary1, M. BOURRIENNE3, J. Desilles4, M. Mazighi5, B. Ho-Tin-Noé6

Abstract Number: PB0619

Clot Collapse in Scanning Electron Microscopy (SEM)

S. Baker1, C. Cai1, Z. de Lange-Loots2, M. Pieters2, M. Guthold1

Abstract Number: OC 76.5

Clot Destabilisation by the Inclusion of Fibrin with Truncations in the αC-region

H. mcPherson1, C. Duval1, T. Feller2, R. Ajjan1, R. Ariëns3

Abstract Number: OC 76.4

CM-352 reduces rivaroxaban-associated ICH by mechanisms dependent on MMP-10 and fibrinolysis inhibition

M. Navarro-Oviedo1, J. Marta-Enguita1, C. Roncal2, J. Rodriguez2, B. Zandio3, R. Lecumberri4, F. Machado1, J. Oyarzabal1, A. Pineda-Lucena1, J. Páramo4, R. Muñoz3, J. Orbe5

Abstract Number: VPB0648

Combination Thrombolytic Therapy Using Electrohydraulic Radial and Focused Shock Waves in The Animal Model of Embolic Common Carotid Artery Occlusion

H. Mehrad

Abstract Number: VPB0637

Comparison between Intermittent Bolus versus Continuous Intravenous Infusion of Tranexamic Acid in Hematological Disorders with Thrombocytopenia (BRAVE Trial)

B. Poojitha1, J. John2, A. Philips2, k. Modak2, P. DS2

Abstract Number: PB0624

Comparison of fibrinogen concentrates to cryoprecipitate in restoring clot integrity and stability against fibrinolytic degradation

C. Whyte1, A. Rastogi2, E. Ferguson3, M. Donnarumma1, N. Mutch1

Abstract Number: PB0643

COVID-19-associated hemostasis alterations and outcomes in acute ischemic stroke patients treated with intravenous thrombolysis

L. Lóczi1, R. Orbán-Kálmándi2, I. Szegedi3, T. Árokszállási4, J. Tóth5, L. Oláh4, L. Csiba6, Z. Bagoly7

Abstract Number: PB0622

Determining the dominant-negative causality of FXIII heterozygous mutations using a bi-cistronic, bi-tagged expression system

H. Javed1, S. Singh2, S. Ramaraje Urs3, J. Oldenburg4, A. Biswas3

Abstract Number: OC 29.4

Development of recombinant antibodies targeting the coagulation factor XIII-B subunit for research and therapeutic use

J. Byrnes, C. Bracken, J. Wells

Abstract Number: VPB0647

DNase 1 unveils the presence and unlocks the thrombolytic potential of intraveneously administered t-PA in large vessel occlusion acute ischemic stroke

L. Di Meglio1, M. Solo Nomenjanahary2, M. BOURRIENNE3, V. Ollivier2, M. Mazighi4, B. Ho-Tin-Noé5, J. Desilles6

Abstract Number: OC 29.5

Dysregulated fibrinogen γ-chain cross-linking in FibγΔ5 mice drives acute liver injury after acetaminophen overdose

L. Poole1, D. Groeneveld1, H. Cline-Fedewa1, M. Flick2, J. Luyendyk3

Abstract Number: PB0630

Early Systemic Administration of a Natural Carboxypeptidase Inhibitor Potentiates tPA-mediated Thrombolysis: Evidence from Real-time Intravital Imaging Analysis of Microthrombi in Mice

N. Mathews1, Y. Suzuki2, N. Honkura2, H. Sano2, T. Urano2

  • 1
  • 2
  • 3
  • Next Page »

« View all themes from the ISTH 2022 Congress

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley